Ikarian Capital, LLC Moderna, Inc. Put Options Transaction History

Ikarian Capital, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $2.91 Million - $4.37 Million	41,857 Added 1713.34%	44,300 $4.41 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $235,529 - $309,308	2,443 New	2,443 $252,000
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $77.9 Million - $141 Million	-600,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $92.8 Million - $158 Million	-850,000 Reduced 58.62%	600,000 $78.6 Million
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $23.4 Million - $60.5 Million	356,100 Added 32.55%	1,450,000 $151 Million
Q3 2020 Nov 16, 2020	BUY	$54.34 - $94.85 $43.1 Million - $75.3 Million	793,900 Added 264.63%	1,093,900 $77.4 Million
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $8.9 Million - $24 Million	300,000 New	300,000 $19.3 Million

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.